Show simple item record

dc.contributorKamel, A.H.EN
dc.contributorEl Barawy, M.A.EN
dc.contributorHashish, M.H.EN
dc.contributorEl Sheikh, S.M.EN
dc.date.accessioned2014-06-17T11:24:18Z
dc.date.available2014-06-17T11:24:18Z
dc.date.issued2003EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/0903/emhj_2003_9_3_364_371.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/119286
dc.description364-371EN
dc.description.abstractWe compared 50 patients with head and neck squamous cell carcinomas [‎cases]‎ and 45 matched healthy controls. Biopsy specimens were taken from tumours and normal tissue of the cases and controls respectively and serial paraffin embedded sections were processed to detect Epstein-Barr [‎EB]‎ viral antigen. We found EB viral proteins in 38% of cases and none in controls, which suggests a positive correlation. Serum samples were also tested for the presence of EB virus IgG by ELISA for comparison with immunohistochemical findings. Patients with positive immunohistochemical staining results had significantly higher mean antibody titres compared with those with negative results. ELISA may be useful in determining the etiology of head and neck cancers, but the results are not unequivocally reliableEN
dc.language.isoenEN
dc.relation.ispartofseriesEMHJ - Eastern Mediterranean Health Journal, 9 (‎3)‎, 364-371, 2003EN
dc.subjectAge DistributionEN
dc.subjectAntibodies, ViralEN
dc.subjectBiopsyEN
dc.subjectCase-Control StudiesEN
dc.subjectDNA, ViralEN
dc.subjectEnzyme-Linked Immunosorbent AssayEN
dc.subjectEpstein-Barr Virus InfectionsEN
dc.subjectHead and Neck NeoplasmsEN
dc.subjectImmunoglobulin GEN
dc.subjectNeoplasm StagingEN
dc.subject.meshCarcinoma, Squamous CellEN
dc.titleEpstein-Barr virus in head and neck squamous cell carcinomaEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record